Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Sales (2016 - 2025)

Historic Return on Sales for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to 0.08%.

  • Ascendis Pharma A's Return on Sales rose 1300.0% to 0.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.27%, marking a year-over-year increase of 7500.0%. This contributed to the annual value of 0.27% for FY2025, which is 7400.0% up from last year.
  • According to the latest figures from Q4 2025, Ascendis Pharma A's Return on Sales is 0.08%, which was up 1300.0% from 0.25% recorded in Q3 2025.
  • Over the past 5 years, Ascendis Pharma A's Return on Sales peaked at 0.08% during Q4 2025, and registered a low of 131.48% during Q2 2021.
  • For the 5-year period, Ascendis Pharma A's Return on Sales averaged around 17.87%, with its median value being 2.8% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -653700bps in 2021, then soared by 1182700bps in 2022.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Return on Sales stood at 1.23% in 2021, then crashed by -598bps to 8.59% in 2022, then soared by 97bps to 0.25% in 2023, then rose by 16bps to 0.21% in 2024, then surged by 62bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q4 2025, 0.25% for Q3 2025, and 0.2% during Q2 2025.